Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma

scientific article published on 22 November 2012

Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1036401959
P356DOI10.1186/1756-9966-31-97
P932PMC publication ID3554474
P698PubMed publication ID23174013
P5875ResearchGate publication ID233749457

P2093author name stringHong Wang
Wei Jiang
Qiong Wang
Keliang Xie
Jinhuan Wang
Ailin Li
Pengcun Li
P2860cites workSecretory mechanisms and intercellular transfer of microRNAs in living cellsQ24603413
Characterization of extracellular circulating microRNAQ24603537
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkersQ24614672
Circulating microRNAs as stable blood-based markers for cancer detectionQ24652098
The functions of animal microRNAsQ27860621
Oncomirs - microRNAs with a role in cancerQ27860773
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14Q27860849
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegansQ27860867
Micro RNAs in animal development.Q52023709
Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: Selective externalization of the receptorQ55062483
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cellsQ27860960
MicroRNA signatures in human cancersQ27860962
MicroRNAs: genomics, biogenesis, mechanism, and functionQ27861070
MicroRNA expression profiles classify human cancersQ28032481
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cellsQ28262214
Extensive modulation of a set of microRNAs in primary glioblastomaQ28263314
Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membraneQ28301729
miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumorsQ28307352
Exosomes: composition, biogenesis and functionQ29547721
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasmaQ29547772
Selective release of microRNA species from normal and malignant mammary epithelial cellsQ33728084
Exosomes: endosomal-derived vesicles shipping extracellular messagesQ33980024
Serum miR-146a and miR-223 as potential new biomarkers for sepsis.Q34100861
Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of gliomaQ35633805
MicroRNA-15b regulates cell cycle progression by targeting cyclins in glioma cellsQ39896800
A specific miRNA signature in the peripheral blood of glioblastoma patientsQ45256953
Micro-RNA-128 (miRNA-128) down-regulation in glioblastoma targets ARP5 (ANGPTL6), Bmi-1 and E2F-3a, key regulators of brain cell proliferationQ45711643
P275copyright licenseCreative Commons Attribution 2.0 GenericQ19125117
P6216copyright statuscopyrightedQ50423863
P921main subjectbiomarkerQ864574
P304page(s)97
P577publication date2012-11-22
P1433published inJournal of Experimental & Clinical Cancer ResearchQ13739415
P1476titlePlasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma
P478volume31

Reverse relations

cites work (P2860)
Q58122179A Critical Overview of Targeted Therapies for Glioblastoma
Q50000797A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarker
Q47998452A microRNA signature from serum exosomes of patients with glioma as complementary diagnostic biomarker.
Q36091092A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas
Q37202515A serum 6-miRNA panel as a novel non-invasive biomarker for meningioma
Q34514808An ER-associated miRNA signature predicts prognosis in ER-positive breast cancer
Q35581594Analysis of Glioblastoma Patients' Plasma Revealed the Presence of MicroRNAs with a Prognostic Impact on Survival and Those of Viral Origin
Q37290626Anti-cancer Therapies in High Grade Gliomas
Q35802967Associations between SOX2 and miR-200b expression with the clinicopathological characteristics and prognosis of patients with glioma
Q86809682Circulating Blood-Borne microRNAs as Biomarkers in Solid Tumors
Q91012634Circulating biomarkers in patients with glioblastoma
Q38095109Circulating biomarkers of CNS tumors: an update.
Q26830329Circulating glioma biomarkers
Q38503895Circulating miRNAs as biomarkers for endocrine disorders
Q38201683Circulating microRNA biomarkers for glioma and predicting response to therapy.
Q34454908Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies
Q41050204Circulating microRNAs as emerging non-invasive biomarkers for gliomas
Q48158056Comparison of microRNA expression levels between initial and recurrent glioblastoma specimens.
Q37588824Comprehensive microRNA profiling of prostate cancer cells after ionizing radiation treatment.
Q38102611Current progress for the use of miRNAs in glioblastoma treatment
Q92400876Decreased let-7b is associated with poor prognosis in glioma
Q35947699Differentially Expressed MicroRNAs in Meningiomas Grades I and II Suggest Shared Biomarkers with Malignant Tumors
Q37226521Emerging biomarkers in glioblastoma
Q38591062Emerging circulating biomarkers in glioblastoma: promises and challenges.
Q36382803Establishment of Lipofection Protocol for Efficient miR-21 Transfection into Cortical Neurons In Vitro.
Q33561359Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively
Q26796590Exploring miRNA-Associated Signatures with Diagnostic Relevance in Glioblastoma Multiforme and Breast Cancer Patients
Q26742027Extracellular MicroRNA in liquid biopsy: applicability in cancer diagnosis and prevention
Q38223605Extracellular vesicles shed by glioma cells: pathogenic role and clinical value
Q39005215Glioblastoma: exosome and microRNA as novel diagnosis biomarkers.
Q38393328Glioblastoma: molecular pathways, stem cells and therapeutic targets
Q42578340Glioma and glioblastoma - how much do we (not) know?
Q35788900Identification of 9 serum microRNAs as potential noninvasive biomarkers of human astrocytoma
Q91715165Liquid Biopsy in Glioblastoma: Opportunities, Applications and Challenges
Q38365590Liquid biopsies in patients with diffuse glioma
Q41820502Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma
Q35036059MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development
Q89880080Micro RNA Molecules as Modulators of Treatment Resistance, Immune Checkpoints Controllers and Sensitive Biomarkers in Glioblastoma Multiforme
Q38590626MicroRNA as potential biomarkers in Glioblastoma
Q64899756MicroRNA based theranostics for brain cancer: basic principles.
Q38108768MicroRNA biomarkers in glioblastoma
Q34409620MicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview.
Q47142132MicroRNA in Glioblastoma: An Overview
Q35943345MicroRNA screening identifies circulating microRNAs as potential biomarkers for osteosarcoma
Q35292347MicroRNA-184 inhibits cell proliferation and invasion, and specifically targets TNFAIP2 in Glioma
Q50853847MicroRNA-342-3p Inhibits the Proliferation, Migration, and Invasion of Osteosarcoma Cells by Targeting Astrocyte-Elevated Gene-1 (AEG-1).
Q35030251MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44
Q38497875MicroRNAs and cell cycle of malignant glioma
Q47449612MicroRNAs as a novel class of diagnostic biomarkers for the detection of osteosarcoma: a meta-analysis
Q27013998MicroRNAs as biomarkers for CNS disease
Q50123796MicroRNAs as biomarkers for human glioblastoma: progress and potential.
Q38205084MicroRNAs as biomarkers in pituitary tumors.
Q26747273MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics
Q61814266Non-Coding RNAs in Glioma
Q48234270Plasma miR-122 as a potential diagnostic and prognostic indicator in human glioma
Q48563610Plasma miR-454-3p as a potential prognostic indicator in human glioma
Q38384219Prognostic Role of microRNA-21 Expression in Brain Tumors: a Meta-analysis
Q35104729Proteogenomics of selective susceptibility to endotoxin using circulating acute phase biomarkers and bioassay development in sheep: a review.
Q35801577ROS-p53-cyclophilin-D signaling mediates salinomycin-induced glioma cell necrosis
Q55461205Regulatory roles of miRNA in the human neural stem cell transformation to glioma stem cells.
Q36797902Role of MicroRNAs in Malignant Glioma
Q37405230Serum miR-95-3p is a diagnostic and prognostic marker for osteosarcoma
Q92222764The Diagnostic Value of MicroRNAs as a Biomarker for Hepatocellular Carcinoma: A Meta-Analysis
Q91599145The Role of Circulating MicroRNA in Glioblastoma Liquid Biopsy
Q90363306The Roles of miRNA in Glioblastoma Tumor Cell Communication: Diplomatic and Aggressive Negotiations
Q26774431Tumor-Associated CSF MicroRNAs for the Prediction and Evaluation of CNS Malignancies
Q92709343UPF1 regulates the malignant biological behaviors of glioblastoma cells via enhancing the stability of Linc-00313
Q53539464miR-200b-3p in plasma is a potential diagnostic biomarker in oral squamous cell carcinoma.
Q41737282miR-27a rs895819 polymorphism and risk of cancer in Chinese population: a meta-analysis
Q52608820miR-342-3p suppresses hepatocellular carcinoma proliferation through inhibition of IGF-1R-mediated Warburg effect.
Q38962553miR-372 regulates glioma cell proliferation and invasion by directly targeting PHLPP2.
Q55456731microRNAs as potential biomarkers for the diagnosis of glioma: A systematic review and meta-analysis.

Search more.